KLRC2 and myalgic encephalomeyelitis/chronic fatigue syndrome: In our study, we observed a lower expression in ME/CFS patients (p < 0.0001), in contrast to the findings by Theorell et al. (33), that did not observe differences in NKG2C expression in ME/CFS patients.